2018 American Transplant Congress

Monday, June 4, 2018

3:30pm-3:42pm

Improved Renal Allograft Survival for Pre-Emptive Paediatric Renal Transplant Recipients in the United Kingdom

M. Marlais,¹ K. Martin,² S. Marks.¹

Concurrent Session: Kidney: Pediatrics - 2  •  Room 3AB

3:30pm-3:42pm

Incidence of Acute Cellular Rejection in Liver Transplant Patients Receiving Direct Acting Antivirals for Hepatitis C Treatment

D. Bley,¹ L. Sagardia,¹ R. Ford,² S. Todd.¹

Concurrent Session: Liver: Viral Hepatitis  •  Room 602/603/604

3:30pm-3:42pm

Mechanisms of Vascularized Bone Marrow Graft Protection of Vascularized Composite Allografts

E. Buckingham, N. Shockcor, W. Hassanein, C. Drachenberg, A. Nam, S. Bartlett, R. Barth.

Concurrent Session: VCA  •  Room 303

3:30pm-3:42pm

Mitochondrial Autophagy Proteins Bnip3 and Nix Maintain Memory B Cell Survival

S. Kodali,¹ H. Sandoval,¹ M. Chen,² J. Wang.¹

Concurrent Session: B-cell / Antibody  •  Room 615/616/617

3:30pm-3:42pm

Outcomes of Pregnancies in Female Liver Transplant Recipients

L. Coscia,¹ D. Armenti,¹ P. Patel,² S. Constantinescu,^1,3 M. Moritz.^1,2,4

Concurrent Session: Liver Retransplantation and Other Complications  •  Room 6A

3:30pm-3:42pm

Post Reperfusion Portal Flow Rate Impacts Liver Allograft and Patient Survival in Patients with Pre Transplant Portal Vein Thrombosis

M. Rizzari, M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud.

Concurrent Session: Surgical Issues (Open, Minimally Invasive): All Organs  •  Room 2AB

3:30pm-3:42pm

Recipient HO-1 Deficiency Decreases Post-Transplant Graft HO-1 Expression and Exacerbates Liver Transplant Damage

S. Kageyama,¹ K. Nakamura,¹ T. Ito,¹ A. Aziz,¹ B. Ke,¹ R. Sossa,² E. Reed,² F. Kaldas,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹

Concurrent Session: IRI Acute Injury: Basic  •  Room 618/619/620

3:30pm-3:42pm

T-Cell Depletion Does Not Increase the Risk of CMV Infection in Donor-Positive, Recipient-Negative Kidney Transplants Due to the Absence of Preformed CMV-Specific Cell-Mediated Immunity

M. Jarque,¹ H. Kaminski,² L. Couzi,² E. Crespo,¹ J. Déchanet-Merville,³ S. Luque,¹ N. Montero,⁴ M. Pascual,⁵ O. Manuel,^5,6 P. Merville,² O. Bestard.^1,4

Concurrent Session: CMV: Bench to Bedside  •  Room 608/609

3:30pm-3:42pm

Treatment of Active Chronic Antibody-Mediated Rejection with Rituximab, IVIG and Plasma Exchange

G. Piñeiro,¹ J. Rovira,² E. De Sousa-Amorim,¹ J. Villarreal,¹ M. Sole,³ I. Revuelta,¹ M. Lozano,⁴ E. Palou,⁴ F. Oppenheimer,¹ J. Campistol,¹ F. Diekmann.^1,2

Concurrent Session: Kidney Chronic Antibody Mediated Rejection  •  Room 4B

3:42pm-3:54pm

APRIL/BLyS Blockade Improves Depletion of Antibody Secreting B Cells Compared to BLyS Blockade Alone in Sensitized Murine Kidney Transplant Model

N. Bath,¹ X. Ding,¹ N. Wilson,² B. Verhoven,¹ A. Sukhwal,¹ L. Coons,¹ S. Panzer,² A. Djamali,² R. Redfield.¹

Concurrent Session: B-cell / Antibody  •  Room 615/616/617